Trastuzumab-associated cardiac events in the Persephone trial.

Authors
Earl, H
Vallier, A
Dunn, J
Loi, S
Ogburn, E
McAdam, K
Hughes-Davies, L
Harnett, A
Abraham, J
Wardley, Andrew M
Cameron, D
Miles, D
Gounaris, I
Plummer, C
Hiller, L
Affiliation
Department of Oncology, University of Cambridge, (Box 193-R4) Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ
Issue Date
2016-12-06

Metadata
Show full item record
Abstract
We report cardiac events in the Persephone trial which compares 6-12 months of adjuvant trastuzumab in women with confirmed HER2-positive, early-stage breast cancer.
Citation
Trastuzumab-associated cardiac events in the Persephone trial. 2016, 115 (12):1462-1470 Br. J. Cancer
Journal
British Journal of Cancer
URI
http://hdl.handle.net/10541/620082
DOI
10.1038/bjc.2016.357
PubMed ID
27875516
Type
Article
Language
en
ISSN
1532-1827
Collections